美康生物：产品“抗Xa检测试剂盒”取得注册证

Group 1 - The core point of the article is that Meikang Bio has recently obtained a medical device registration certificate for its "Anti-Xa Test Kit" from the Zhejiang Provincial Drug Administration [1] - Meikang Bio's revenue composition for the year 2024 is projected to be 100.0% from medical devices [1] - As of the report, Meikang Bio has a market capitalization of 3.9 billion yuan [1]